Neurocysticercosis and epilepsy

Epilepsies

Volumn 22, Issue 2, 2010, Pages 126-133

  Medina, Marco T ^a   Dubón Murcia, Sofía A ^a   Aguilar Estrada, Rafael L ^a   Chaves Sell, F ^b   Bu, Jeaneth ^a  

^a NATIONAL AUTONOMOUS UNIVERSITY OF HONDURAS   (Honduras)

^b Hospital Clinica Biblica   (Costa Rica)

Author keywords

Epidemiology; Epilepsy; Imaging; Neurocysticercosis; Prevention

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; DEXAMETHASONE; NONSTEROID ANTIINFLAMMATORY AGENT; PRAZIQUANTEL; STEROID;

CLINICAL TRIAL; COMMUNITY CARE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; EPILEPSY; EPILEPTOGENESIS; GENE; GLIOSIS; HEALTH EDUCATION; HUMAN; IMMUNOLOGICAL PROCEDURES; INCIDENCE; INFLAMMATION; NEUROCYSTICERCOSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITE MIGRATION; PREVALENCE; PUBLIC HEALTH SERVICE; REVIEW; SYMPTOMATIC EPILEPSY;

EID: 77955856653     PISSN: 11496576     EISSN: 19506937     Source Type: Journal    
DOI: 10.1684/epi.2010.0310     Document Type: Review

References (31)

1. De Giorgio CM, Medina MT, Durón R, Zee C, Escueta SP. Neurocysticercosis. Epilepsy Curr 2004; 4: 107-11.
2. Del Brutto OH, Sotelo J. Cysticercosis. In: Feldeman E, ed. Current Diagnosis in Neurology. St Louis: Mosby, 1994: 125-9.
3. Del Brutto OH. Neurocysticercosis. Rev Neurol 1999; 29: 456-66.
4. Del Brutto OH, Rajshekhar V, White Jr AC, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57: 177-83.
5. Dubon S, Duron RM, Medina MT, Aguilar-Estrada R, Thompson A, Martinez L. Prognosis of neurocysticercosis: eight years of follow-up from a population-based study in Salama, Honduras. American Epilepsy Society. Epilepsia 2005; 46 (Suppl 8): 362 (abstract).
6. Duron RM, Medina MT, Bu-Figueroa J, et al. Brain calcification with perilesional edema and epileptic seizures: a new stage of neurocysticercosis. Epilepsia 2003; 44 (Suppl. 9): 182 (abstract).
7. Duron RM, Garcia HH, Kurdi A, Medina MT, Rodriguez LC. Neuroinfections. In: World Health Organization editors. Neurological Disorders: Public Health Challenges. 1ed. Geneva; 2006; 103-4.
8. Garcia HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiolo Rev 2002; 15: 747-56.
9. Garcia HH, Gonzalez AE, Evans CW, Gilman RH, Cysticercosis Working Group in Peru. Taenia Solium cysticercosis. Lancet 2003; 362: 547-56.
10. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, et al. A trial of anti-parasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004; 350: 249-58.
11. García HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet (Neurol) 2005; 4: 653-61.
12. Gupta RK, Kumar R, Chawla S, Pradhan S. Demonstration of scolex within calcified cysticercus cyst: its possible role in the pathogenesis of perilesional edema. Epilepsia 2002; 43: 1502-8. (Pubitemid 35429768)
13. Herrera G. Diagnosis of neurocysticercosis by computed axial tomography. In: García HH, Martinez SM, eds. Teniasis/Cisticercosis por T. solium. Lima: Editorial Universo, 1996: 259-68.
14. Lucato LT, Guedes MS, Sato JR, Bacheschi LA, Machado LR, Leite CC. The role of conventional MR imaging sequences in the evaluation of neurocysticercosis : impact on characterization of the scolex and lesion burden. Am J Neuroradiol 2007; 28: 1501-4.
15. Medina MT, Rosas E, Rubio-Donnadieu F, et al. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990; 150: 325-7.
16. Medina MT, Duron RM, Martinez L, et al. Prevalence, incidence and etiology of epilepsies in Rural Honduras: The Salama Study. Epilepsia 2005; 46: 124-31.
17. Medina MT, De Giorgio CM. Introduction to neurocysticercosis: a worwilde epidemic. Neurosurg Focus 2002; 12: 1.
18. Medina MT, Aguilar Estrada R, Alvarez A, et al. Community intervention to reduce rate of preventable Epilepsy from Neurocysticercosis : The Salama Study. (Submitted to Epilepsia 2010).
19. Nash TE, Patronas NJ. Edema associated with calcified lesions in Neurocysticercosis. Neurology 1999; 53: 777-81.
20. Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004; 62: 1934-8.
21. Nicoletti A, Bartoloni A, Reggio A, et al. Epilepsy, cysticercosis and toxocariosis: a population-based control study in rural Bolivia. Neurology 2002; 58: 1256-61.
22. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L, Preux PM. Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa. Epilepsia 2003; 44: 950-5. (Pubitemid 36842186)
23. Osborn AG, Preece MT. Intracranial cysts : radiologic-pathologic correlation and imaging approach. Radiology 2006; 239: 650-64.
24. Osborn AG. Brain tumors and tumorlike masses : classification and differential diagnosis. In: Osborn AG, ed. Diagnostic neuroradiology. St Louis, Mo: Mosby, 1994: 408-30.
25. Rajshekhar V, Venkat Raghava M, Prabhakaran V, Oommen A, Muliyil J. Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 2006; 67: 2135-9.
26. Román G, Sotelo J, Del Brutto O, et al. A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ 2000; 78: 399-406.
27. Sánchez AL, Lindbäck J, Schantz PM, et al. A population-based case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol 1999a; 93: 247-58. (Pubitemid 29355873)
28. Sanchez AL, Ljungström I, Medina MT. Diagnosis of human neurocysticercosis in endemic countries: a clinical study in Honduras. Parasitol Int 1999b; 48: 81-9. (Pubitemid 29158929)
29. Sheth TN, Pillon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. Am J Neuroradiol 1998; 19: 79-82. (Pubitemid 30430587)
30. Sotelo J, Del Brutto OH. Review of Neurocysticercosis. Neurosurg Focus 2002; 12: 1-7.
31. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004; 63: 1559-64.